Asserter profile

MESOBLAST INTERNATIONAL SÀRL

operating company1 patents now2 ever0 cases filed during tenure3 connections

Also seen as: Mesoblast International SÀRL

Two-hop network

Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.

flowchart LR
    Nmesoblast_s_rl["MESOBLAST INTERNATIONAL SÀRL"]
    Nosiris_therapeutics["OSIRIS THERAPEUTICS, INC."]
    Nhercules_capital_as_administrative_and_collateral_agent["HERCULES CAPITAL, INC., AS ADMINISTRATI…"]
    Nnqp_spv_ii_as_administrative_agent_and_collateral_agent["NQP SPV II, L.P., AS ADMINISTRATIVE AGE…"]
    Nyoung_randell_g_danilkovich_alla_newman_robert_e_jr_tom_sams["YOUNG, RANDELL G., DANILKOVICH, ALLA, N…"]
    Nton_christopher["TON, CHRISTOPHER"]
    Ndanilkovitch_alla_ton_christopher_tom_samson["DANILKOVITCH, ALLA; TON, CHRISTOPHER; T…"]
    Nmesoblast_sarl["MESOBLAST INTERNATIONAL SARL"]
    Ncase_western_reserve_university["Case Western Reserve University"]
    Nosiris_therapeutics -->|"2013 · ASSIGNMENT OF ASSIGNORS INTEREST · 8637004"| Nmesoblast_s_rl
    Nmesoblast_s_rl -->|"2018 · SECURITY AGREEMENT · 8637004"| Nhercules_capital_as_administrative_and_collateral_agent
    Nmesoblast_s_rl -->|"2018 · SECURITY AGREEMENT · 8637004"| Nnqp_spv_ii_as_administrative_agent_and_collateral_agent
    Nosiris_therapeutics -->|"2013 · Assignment · 5197985"| Nmesoblast_s_rl
    Nyoung_randell_g_danilkovich_alla_newman_robert_e_jr_tom_sams -->|"2009 · ASSIGNMENT OF ASSIGNORS INTEREST · 8637004"| Nosiris_therapeutics
    Nton_christopher -->|"2009 · ASSIGNMENT OF ASSIGNORS INTEREST · 8637004"| Nosiris_therapeutics
    Ndanilkovitch_alla_ton_christopher_tom_samson -->|"2020 · ASSIGNMENT OF ASSIGNORS INTEREST · 11708560"| Nosiris_therapeutics
    Nosiris_therapeutics -->|"2020 · ASSIGNMENT OF ASSIGNORS INTEREST · 11708560"| Nmesoblast_sarl
    Ncase_western_reserve_university -->|"2006 · Assignment · 5197985"| Nosiris_therapeutics
    classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
    classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
    classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
    classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
    classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
    class Nmesoblast_s_rl focal
    class Nosiris_therapeutics operating
    class Nmesoblast_sarl operating

Patents currently held (1)

Patents previously held (1)

Connected entities (3)

Correspondent attorneys (2)

Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.